Former India goalkeeper Akash Chikte has been handed a two-year suspension for a positive test for steroid Nandrolone in an out-of-competition test. The sample was collected on February 27 this year with the B sample tested in April.
The final hearing by the Anti-Doping Disciplinary Panel was held on August 16 this year and the decision came on October 3 that also mentions the period of suspension commencing from March 27, 2018, when the player was provisionally suspended after the first review.
According to the NADA report, Chikte’s sample was collected during random checking at the national camp in Bengaluru and tested positive for Nandrolone beyond acceptable limits of 15ng/ml.
With the B sample also testing positive, Chikte contended that he had taken injections prescribed by a doctor in Yavatmal for pain in his left foot after being hit during the camp. He also mentioned as suffering from fever and urinary tract infection at the time of sample collection, both of which are part of the SAI medical records.
However, NADA’s contention was that Chikte had neither informed the Yavatmal doctor of his being an elite sportsman nor bothered to obtain Therapeutic Use of Exemption (TUE) or inform the sample collecting officer of the medicines he had taken.
The three-member panel, including Olympian Jagbir Singh and Dr. Sanjeev Kumar from the Army Medical Corps, accepted Chikte’s plea that the use of Nandrolone was not intentional, thereby leading to only a two-year suspension instead of the WADA-mandated four years.
Meanwhile, another hockey player, Bharat Singh, has also reportedly tested positive for Methylhexaniemine (MHA) during the recent inter-services championship and disciplinary process is still on.
Comments
SHARE